QA: Endocyte INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001235007_2017_Endocyte_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001235007, Endocyte INC

  xvar xval
0 AssetsCurrent 140,255,710
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,205,077
3 remainder_Assets 33,567
4 LiabilitiesCurrent 5,562,174
5 LiabilitiesNoncurrent 2,873
6 remainder_Liabilities 781,944
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 17,207,939
9 ResearchAndDevelopmentExpense 27,374,111
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,080,779
13 remainder_ComprehensiveNetIncome 47,343
  yvar yval
0 Assets 143,494,354
1 Liabilities 6,346,991
2 Expenses 44,582,050
3 Revenues 0
4 StockholdersEquity 137,147,363
5 NetIncome -43,501,271
6 ComprehensiveNetIncome -43,477,600
7 BaseVar 97,775,758
8 EconomicCapitalRatiobeforeLimitedLiability 3.41
9 EconomicCapitalRatio 3.97

Edgar->Model Mapping

Feature Distribution

Change over Time